Palatin Unveils Promising Preclinical Data For Diabetic Retinopathy Treatments At ARVO 2025
9/5 23:42
(RTTNews) - Palatin Technologies, Inc. (PTNT), a biopharmaceutical company advancing melanocortin-based therapies, shared new preclinical findings at the 2025 ARVO Annual Meeting....